Abstract
Scaffolds, growth factors, and cells are three essential components in regenerative medicine. Nonwoven filters, which capture cells, provide a scaffold that localizes and concentrates cells near injured tissues. Further, the cells captured on the filters are expected to serve as a local supply of growth factors. In this study, we investigated the growth factors produced by cells captured on nonwoven filters. Nonwoven filters made of polyethylene terephthalate (PET), biodegradable polylactic acid (PLA), or chitin (1.2–22 μm fiber diameter) were cut out as 13 mm disks and placed into cell-capturing devices. Human mesenchymal stem cells derived from adipose tissues (h-ASCs) and peripheral blood cells (h-PBCs) were captured on the filter and cultured to evaluate growth factor production. The cell-capture rates strongly depended on the fiber diameter and the number of filter disks. Nonwoven filter disks were composed of PET or PLA fibers with fiber diameters of 1.2–1.8 μm captured over 70 % of leukocytes or 90 % of h-ASCs added. The production of vascular endothelial growth factor (VEGF), transforming growth factor β1, and platelet-derived growth factor AB were significantly enhanced by the h-PBCs captured on PET or PLA filters. h-ASCs on PLA filters showed significantly enhanced production of VEGF. These enhancements varied with the combination of the nonwoven filter and cells. Because of the enhanced growth factor production, the proliferation of human fibroblasts increased in conditioned medium from h-PBCs on PET filters. This device consisting of nonwoven filters and cells should be investigated further for possible use in the regeneration of impaired tissues.
Similar content being viewed by others
References
Shimizu A, Masuda Y, Mori T, Kitamura H, Ishizaki M, Sugisaki Y, Fukuda Y. Vascular endothelial growth factor165 resolves glomerular inflammation and accelerates glomerular capillary repair in rat anti-glomerular basement membrane glomelulonephritis. J Am Soc Nephrol. 2004;15:2655–65.
Matsumoto K, Nakamura T. Hepatocyte growth factor; renotropic role and potential therapeutics for renal diseases. Kidney Int. 2001;59:2023–38.
Takenaka Y. Lymphocytapheresis. Artif Organs. 1996;20:914–6.
Ito K, Aoyama T, Fukiage K, Otsuka S, Furu M, Jin Y, Nasu A, Ueda M, Kasai Y, Ashihara E, Kimura S, Maekawa T, Kobayashi A, Yoshida S, Niwa H, Otsuka T, Nakamura T, Toguchida A. novel method to isolate mesenchymal stem cells from bone marrow in a closed system using a device made by nonwoven fabric. J Tissue Eng Part C Methods. 2010;16:81–91.
Jackson WM, Nesti LJ, Tuan RS. Mesenchymal stem cell therapy for attenuation of scar formation during wound healing. Stem Cell Res Ther. 2012;3:20–8.
Soleymaninejadian E, Pramanik K, Samadian E. Immunomodulatory properties of mesenchymal stem cells: cytokines and factors. Am J Reprod Immunol. 2012;67:1–8.
Li Y, Ma T, Yang ST, Kniss DA. Thermal compression and characterization of three-dimensional nonwoven PET matrices as tissue engineering scaffolds. Biomaterials. 2001;22:609–18.
Takahashi Y, Tabata Y. Effect of the fiber diameter and porosity of non-woven PET fabrics on the osteogenic differentiation of mesenchymal stem cells. J Biomater Sci Polym Ed. 2004;15:41–57.
Langer R, Vacanti JP. Tissue engineering. Science. 1993;260:920–6.
Vacanti CA, Langer R, Schloo B, Vacanti JP. Synthetic polymers seeded with chondrocytes provide a template for new cartilage formation. Plast Reconstr Surg. 1991;88:753–9.
Francesko A, Tzanov T. Chitin, chitosan and derivatives for wound healing and tissue engineering. Adv Biochem Eng Biotechnol. 2011;125:1–27.
Nishimura N, Kuroda T, Mizoguchi Y, Watanabe H, Rikumaru H, Umegae M. Advanced methods for leukocyte removal by blood filtration. In: Brozovic B, editor. Proceedings of the international workshop: The role of leukocyte depletion in blood transfusion practice. Oxford: Blackwell Scientific Publications; 1988. p. 35–40.
Gregory CA, Ylostalo J, Prockop DJ. Adult bone marrow stem/progenitor cells (MSCs) are preconditioned by microenvironmental “niches” in culture: a two-stage hypothesis for regulation of MSC fate. Sci STKE. 2005;294:pe37.
Seppä H, Grotendorst G, Seppä S, Schiffmann E, Martin GR. Platelet-derived growth factor in chemotactic for fibroblasts. J Cell Biol. 1982;92:584–8.
Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA. 1986;83:4167–71.
Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen. 2008;16:585–601.
Acknowledgments
The authors thank Mr. Tomohisa Inoue of Shinwa Co., Ltd., Mr. Yoshio Katsuta of Fusyokufu Joho, and Ms. Mikiko Ariga of Asahi Kasei Fibers Corporation for providing the nonwoven filters. The authors also thank Ms. Kasumi Suzuki, Ms. Takami Kobayashi, Ms. Miwa Sakata, Mr. Tomoyuki Miyazaki, Mr. Yuta Saito, and Mr. Shun Kobayashi for technical assistance. This work was partly supported by a research grant from Aichi Kidney Foundation and JSPS KAKENHI Grant Number 25410232.
Conflict of interest
Mikitomo Yasutake, General Manager, and Ushio Iwamoto, Chief Researcher, are employees of Asahi Kasei Corporation Co., Ltd. (Cell Therapy Technology, Healthcare R&D Center) and have the stock of the company. Yasuo Tokushima is an employee of Asahi Kasei Medical Co., Ltd. (Manager of Scientific and Technical Department, Japan Operation Division, Blood Purification Business Unit), and has the stock of Asahi Kasei Corporation Co., Ltd.. Nobuya Kitaguchi has the stock of Asahi Kasei Corporation Co., Ltd.. The other authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
H. Hori, U. Iwamoto contributed equally.
Rights and permissions
About this article
Cite this article
Hori, H., Iwamoto, U., Niimi, G. et al. Appropriate nonwoven filters effectively capture human peripheral blood cells and mesenchymal stem cells, which show enhanced production of growth factors. J Artif Organs 18, 55–63 (2015). https://doi.org/10.1007/s10047-014-0794-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10047-014-0794-9